Academic Health Science Centres as Vehicles for Knowledge Mobilisation in Australia? A Qualitative Study.

Academic Health Centre Australia Knowledge Mobilisation Research Impact Research Translation

Journal

International journal of health policy and management
ISSN: 2322-5939
Titre abrégé: Int J Health Policy Manag
Pays: Iran
ID NLM: 101619905

Informations de publication

Date de publication:
01 06 2022
Historique:
received: 11 05 2020
accepted: 28 11 2020
pubmed: 17 2 2021
medline: 10 5 2022
entrez: 16 2 2021
Statut: epublish

Résumé

Despite increasing investments in academic health science centres (AHSCs) in Australia and an expectation that they will serve as vehicles for knowledge translation and exchange, there is limited empirical evidence on whether and how they deliver impact. The aim of this study was to examine and compare the early development of four Australian AHSCs to explore how they are enacting their impact-focused role. A descriptive qualitative methodology was employed across four AHSCs located in diverse health system settings in urban and regional locations across Australia. Data were collected via semi-structured interviews with 15 academic, industry and executive board members of participating AHSCs. The analysis combined inductive and deductive elements, with inductive categories mapped to deductive themes corresponding to the study aims. AHSCs in Australia are in an emergent state of development and are following different pathways. Whilst varied approaches to support research translation are apparent, there is a dominant focus on structure and governance, as opposed to action-oriented roles and processes to deliver strategic goals. Balancing collaboration and competition between partners presents a challenge, as does identifying appropriate ways to evaluate impact. The early stage of development of AHSCs in Australia presents an important opportunity for formative learning and evaluation to optimise their enactment of knowledge mobilisation processes for impact.

Sections du résumé

BACKGROUND
Despite increasing investments in academic health science centres (AHSCs) in Australia and an expectation that they will serve as vehicles for knowledge translation and exchange, there is limited empirical evidence on whether and how they deliver impact. The aim of this study was to examine and compare the early development of four Australian AHSCs to explore how they are enacting their impact-focused role.
METHODS
A descriptive qualitative methodology was employed across four AHSCs located in diverse health system settings in urban and regional locations across Australia. Data were collected via semi-structured interviews with 15 academic, industry and executive board members of participating AHSCs. The analysis combined inductive and deductive elements, with inductive categories mapped to deductive themes corresponding to the study aims.
RESULTS
AHSCs in Australia are in an emergent state of development and are following different pathways. Whilst varied approaches to support research translation are apparent, there is a dominant focus on structure and governance, as opposed to action-oriented roles and processes to deliver strategic goals. Balancing collaboration and competition between partners presents a challenge, as does identifying appropriate ways to evaluate impact.
CONCLUSION
The early stage of development of AHSCs in Australia presents an important opportunity for formative learning and evaluation to optimise their enactment of knowledge mobilisation processes for impact.

Identifiants

pubmed: 33590737
doi: 10.34172/ijhpm.2020.247
pmc: PMC9309908
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

840-846

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Références

Implement Sci. 2016 Feb 09;11:17
pubmed: 26860631
Med J Aust. 2014 Dec 11;201(11):636-8
pubmed: 25495302
Implement Sci. 2015 Nov 20;10:162
pubmed: 26589972
Glob Qual Nurs Res. 2017 Nov 24;4:2333393617742282
pubmed: 29204457
J Health Organ Manag. 2018 Apr 9;32(2):279-297
pubmed: 29624138
Soc Sci Med. 2015 Aug;138:192-200
pubmed: 26117554
Med J Aust. 2011 Jan 17;194(2):59-60
pubmed: 21241215
Health Policy. 2014 Sep;117(3):382-91
pubmed: 25088488
Implement Sci. 2013 Sep 05;8:104
pubmed: 24007259
Implement Sci. 2018 Aug 15;13(1):111
pubmed: 30111339

Auteurs

Alexandra Edelman (A)

College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD, Australia.

Robyn Clay-Williams (R)

Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia.

Michael Fischer (M)

Centre for Sustainable Human Resource Management and Wellbeing, Australian Catholic University, Melbourne, VIC, Australia.

Roman Kislov (R)

Manchester Metropolitan University, Manchester, UK.
The University of Manchester, Manchester, UK.

Alison Kitson (A)

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.

Ian McLoughlin (I)

Monash Business School, Monash University, Melbourne, VIC, Australia.

Helen Skouteris (H)

Monash Centre for Health Research and Implementation, Monash University, Melbourne, VIC, Australia.
Warwick Business School, University of Warwick, Coventry, UK.

Gillian Harvey (G)

Adelaide Nursing School, University of Adelaide, Adelaide, SA, Australia.
Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH